Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros

Ano de publicação
Tipo de documento
Intervalo de ano
1.
researchsquare; 2023.
Preprint em Inglês | PREPRINT-RESEARCHSQUARE | ID: ppzbmed-10.21203.rs.3.rs-2899021.v1

RESUMO

Background Complicated grief (CG) resulting from poor adaptation to the death of a close person may have predisposed the presence of other mental health problems in older adults in Peru during the COVID-19 pandemic. The aim of our study was to assess the association between CG and the presence of anxiety, depression, and suicidal risk in older adults in Peru in the context of COVID-19 pandemic.Methods We conducted a cross-sectional analysis using data from the "Socioemotional evaluation form" applied in 2020 to assess the presence of mental health problems in older adults being attended in the Peruvian Social Security (EsSalud). For our study we included older adults who reported the death of a close person during the last 6 months when this assessment was performed. CG, depression, anxiety, and risk of suicide was originally evaluated using validated questionnaires. The association between CG and the presence of mental health problems was calculated through multivariate analysis where prevalence ratios (PR) were estimated with 95% confidence intervals (CI).Results Of the 249 older adults included, 175 (70.3%) were female with a median age of 71 years (interquartile range: 9) and 35 (14.1%) reported the presence of CG. It was found that CG in this population was associated with the presence of anxiety (PR: 1.35, 95% CI: 0.98 to 1.85), depression (PR: 1.44, 95% CI: 1.06 to 1.95), and suicidal risk (PR: 2.84, 95% CI: 1.06 to 7.59).Conclusions CG predisposes the presence of mental health problems in older adults in Peru. It is important to implement measures that facilitate its prevention and proper management of this condition in this population, especially in context of high population mortality such as the COVID-19 pandemic.


Assuntos
Transtornos de Ansiedade , Transtorno Depressivo , COVID-19
2.
Fallah Hashemi; Lori Hoepner; FARAHNAZ Soleimani Hamidinejad; Daniela Haluza; Sima Afrashteh; Alireza Abbasi; Elma Omeragić; Belma Imamović; Narin A. Rasheed; Taqi Mohammed Jwad Taher; Fitri Kurniasari; Dhuha Youssef Wazqar; Özge Ceren Apalı; Ayca Demir Yildirim; Bo Zhao; Zaruhi Kalikyan; Cui Guo; Andrea Chong Valbuena; Magdalena Mititelu; Carolina Martínez Pando; Maria Saridi; Aikaterini Toska; Magalys Lopez Cuba; Precious Kwablah Kwadzokpui; Niguse Tadele; Tohfa Nasibova; Stefanie Harsch; Luvsan Munkh-Erdene; Wafaa Menawi; Efi Evangelou; Antoniya Dimova; Dimitar Marinov; Teodora Dimitrova; Anna Shalimova; Howieda Fouly; Anna Suraya; Juliana Pereira da Silva Faquim; Bouadil Oumayma; Maria Antonieta Annunziato; Rezarta Lalo; Evridiki Papastavrou; Anju D. Ade; Susanna Caminada; Svetlana Stojkov; Carmen Gloria Narvaez; lutendo Sylvia Mudau; Ines Rassas; Daphnee Michel; Nur Sema Kaynar; Sehar Iqbal; Halla Elshwekh; Irin Hossain; Sadeq AL-Fayyadh; Aniuta Sydorchuk; Dua’a Mohammad Hasan Alnusairat; Asli Mohamed Abdullahi; Neelam Iqbal; Apsara Pandey; Brenda Gómez-Gómez; Aysenur Gunaydin Akyildiz; Elena Morosan; Daniella Dwarica; Gantuya Dorj; Sumaya Yusuf Hasan; Noha M. Alshdefat; Bojana Knezevic; Wendy Valladares; Cecilia Severi; Sofia Cuba Fuentes; Sofia Augusto; Elizaveta Sidorova; Anita Dewi Moelyaningrum; Tafaul Alawad; Atiqa Khalid; Elehamer Nafisa Mhna Kmbo; Anna Mihaylova; Oxana Tsigengagel; Aziza Menouni; Agnieszka Wojtecka; Rozita Hod; Yusuf Banke Idayat; khadija Othman; Rim M. Harfouch; Tsonco Paunov; Meruyert Omar; Nana Christine Benderli; Globila Nurika; Sana Amjad; Salma Elnoamany; Fatma Elesrigy; Marwa Mamdouh Shaban; Doménica Acevedo-López; Maria Kartashova; Atika Khalaf; Sabah Abdullah Jaafar; Taisir A. Kadhim; Nada Ab. Hweissa; Yulong Teng; Fatima Elbasri Abuelgasim Mohammed Yagoub; Thayahlini Sasikumar; Christabel Nangandu Hikaambo; Aditi Kharat; ulyana Lyamtseva; Maya Arfan Aldeeb; Natalia Pawlas; Lkhagvasuren Khorolsuren; Roopeshwaree Pallavi Koonjul; Halima Boubacar Maïnassara; Priyanka Chahal; Rose W Wangeci; Ainur B. Kumar; Irina Zamora-Corrales; Stella Gracy; Maimouna Mahamat; Jakub Adamczyk; Haliza Abdul Rahman; Lolita Matiashova; Omneya Ezzat Elsherif; Nazdar Ezzaddin Rasheed Alkhateeb; Yamilé Aleaga; Shima Bahrami; Shaimaa Rahem Al-salihy; Paula Cabrera-Galeana; Mladena Lalic-Popovic; Eugenie Brown-Myrie; Divya Bhandari; Cinderella Akbar Mayaboti; Svetlana Stanišić; Sanda Kreitmayer Pestic; Muhammed Yunus Bektay; Haleama Al Sabbah; Saber Hashemi; Bouchetara Assia; Anne-Sophie Merritt; Zhian Ramzi; Himawatee Baboolal; Juman Isstaif; Rula Shami; Rahma Saad; Temwanani Nyirongo; Mohammad Hoseini.
researchsquare; 2022.
Preprint em Inglês | PREPRINT-RESEARCHSQUARE | ID: ppzbmed-10.21203.rs.3.rs-2267501.v1

RESUMO

COVID-19 has affected all aspects of human life so far. From the outset of the pandemic, preventing the spread of COVID-19 through the observance of health protocols, especially the use of sanitizers and disinfectants was given more attention. Despite the effectiveness of disinfection chemicals in controlling and preventing COVID-19, there are critical concerns about their adverse effects on human health. This study aims to assess the health effects of sanitizers and disinfectants on a global scale. A total of 91056 participants from 154 countries participated in this cross-sectional study through an electronic questionnaire. Results implied that detergents (67%), alcohol-based materials (56%), and chlorinated compounds (32%) were the most commonly used types of sanitizers and disinfectants. Most frequently reported health issues include skin complications 48.8% and respiratory complications 29.8%. The Chi-square test showed a significant association between chlorinated compounds with all possible health complications under investigation (p-value < 0.001). Examination of risk factors based on multivariate regression analysis showed that alcohols-based materials were associated with skin complications (OR, 1.98; 95%CI, 1.87–2.09), per-chlorine was associated with eye complications (OR, 1.83; 95%CI, 1.74–1.93), and highly likely with itching and throat irritation (OR, 2.00; 95%CI, 1.90–2.11). Furthermore, formaldehyde was associated with a higher prevalence of neurological complications (OR, 2.17; 95%CI, 1.92–2.44). The findings of the current study suggest that health authorities need to implement more awareness programs about the side effects of using sanitizers and disinfectants during viral epidemics.


Assuntos
COVID-19 , Prurido , Dermatopatias Vasculares , Doenças do Sistema Nervoso Central
3.
medrxiv; 2022.
Preprint em Inglês | medRxiv | ID: ppzbmed-10.1101.2022.01.24.22269781

RESUMO

BackgroundCOVID-19 vaccination may reduce anxiety and depression. However, the pandemic significantly impacted the elderly from low-middle-income countries. Therefore, we aimed to estimate the effect of vaccination against COVID-19 on the emotional health of older adults. MethodsWe selected a nationally stratified sample of non-hospitalized adults aged 60 to 79 years who intended to receive the COVID-19 vaccine or had already received it during recruitment. We assess the fear, anxiety, and worry about COVID-19, general anxiety, and depression at baseline and after a month. We estimated the adjusted odds ratios (aOR) and 95% confidence intervals (95% CI) for each altered emotional health outcomes in those who had one and two doses, compared with those who were not vaccinated using multilevel logistic regression with mixed effects. ResultsWe recruited 861 older adults. Loss to follow-up was 20.8%. At baseline, 43.9% had only one dose of the vaccine, and 49.1% had two doses. In the analysis during follow-up, those who had two doses had less fear (ORa: 0.19; CI95%: 0.07 to 0.51) and anxiety to COVID-19 (ORa: 0.45; CI95%: 0.22 to 0.89), compared to non-vaccinated. We observed no effects in those with only one dose. LimitationsInability to obtain the planned sample size for primary analysis. There is a selection bias during recruitment and a measurement bias because of self-reported vaccination. ConclusionsCOVID-19 vaccination with two doses in elders improves the perception of COVID-19 infection consequences. This information could be integrated into the vaccination campaign as its beneficial effect. HighlightsO_LIUp to 90% of elders in a Peruvian sample had at least one dose of COVID-19 vaccine C_LIO_LITwo doses of COVID-19 vaccine reduced the levels of fear and anxiety for COVID-19 C_LIO_LIOnly one dose of vaccine didnt had effect in any emotional mental outcome C_LI


Assuntos
COVID-19 , Transtornos de Ansiedade , Transtorno Depressivo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA